Same Indication

Memantine vs Osimertinib

Memantine vs Osimertinib: Overview

This comparison examines the pharmacological differences between Memantine and Osimertinib.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Memantine — 60-80 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N; Osimertinib — C28H33N7O2.

Molecular Weight: Memantine — 179.3080 g/mol; Osimertinib — 499.6050 g/mol.

Type: Memantine — Small molecule; Osimertinib — Small molecule.